Home / Health / Obesity Drug Pioneers Win Million-Euro Award
Obesity Drug Pioneers Win Million-Euro Award
17 Nov
Summary
- Three scientists honored for revolutionary obesity and diabetes treatments.
- Award recipients' research enables modern GLP-1-based therapies.
- Broermann Medical Innovation Award includes one million euros.
The Broermann Medical Innovation Award 2026 has been presented to Prof. Svetlana Mojsov, Prof. Dr. Richard DiMarchi, and Prof. Dr. Dr. h.c. Matthias H. Tschöp. The ceremony took place at the Hessian State Chancellery, with Minister-President Boris Rhein presenting the award. This honor, totaling one million euros, recognizes their groundbreaking research in metabolic diseases and obesity therapies.
Their fundamental work has been crucial in enabling current GLP-1-based treatments for diabetes and obesity. The award celebrates their dedication to scientific curiosity and its translation into medical progress that significantly improves patient lives. Prof. Mojsov's early identification of GLP-1's role and Prof. DiMarchi and Prof. Tschöp's development of multi-hormone co-agonists form the basis of these revolutionary therapies.